Company Research Report: Savana

Company Overview

• Name: Savana

• Mission: To revolutionize healthcare through artificial intelligence by transforming electronic medical records into actionable medical insights.

• Founded: 2014

• Founder: Ignacio H. Medrano

• Key People: Ignacio H. Medrano

• Headquarters: No specific headquarters location provided.

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Savana is recognized for its AI-generated clinical evidence and is a top provider of Health Economics and Outcomes Research (HEOR) solutions in Europe for 2023.

Products

NLPaaS

• Description: An AI-powered Natural Language Processing (NLP) service.

• Key Features:

• Structured 5+ billion clinical documents.

• Available in 6 languages across 10+ countries.

DeID Station

• Description: A Clinical Data Anonymization Solution.

• Key Features: Capable of anonymizing both structured and unstructured data across more than 35 million documents.

HDLake

• Description: A platform that consolidates, harmonizes, and curates clinical data into a unified structure.

• Key Features: Enhances clinical management, research, and analysis capabilities.

Recent Developments

• 2023 European Patent: Developed a Patient Privacy mathematical formula.

• Recognition: Included in Forbes' "2023 Changemakers" list for contributions to transforming healthcare data analytics.

• ISO Certification: Certified with ISO 27001 for information security management.

• Platform Innovation: Developed platforms to enable research and health outcomes registries and facilitate real-world evidence generation.

Publications and Research

Savana has numerous peer-reviewed publications focused on various aspects of healthcare and AI, including studies on:

• Cardiovascular events and risks in diabetic patients.

• Cancer prevalence in hypothyroid patients.

• AI applications in pneumology and COPD hospitalizations.

• Real-world evidence on patient management in chronic lymphocytic leukemia.

• Development of predictive models for clinical outcomes.

Partnerships and Collaborations

• Supported by European Union Funds: Including Next Generation EU Funds and European Regional Development Funds for projects like DeID Station.

• Healthcare Systems Collaboration: Savana works directly with healthcare systems to extract high-quality phenotype data for creating high-validity registries and pragmatic trials.

Conclusion

Savana is a leading player in the integration of artificial intelligence within healthcare systems, focusing on leveraging NLP to transform clinical data for enhanced research and real-world evidence generation. While detailed financials and employee numbers are not available, the company's impact is significant, extending across multiple countries and languages, with a strong focus on transforming patient care through technological innovation.